Interestingly, Ron Wevers and Eva Morava recently discovered a pathogenic variant in PI4K2A, encoding phosphatidylinositol 4‐kinase type 2‐alpha as the cause of a CL condition with strong neurological features, movement disorders and a marked myopathy.31 Here, PI4K2A is linked to movement disorder.